Toggle navigation
News
OK
NewsOK
News
Weather
Opinion
Business
Sports
Life
Photos
Videos
Brandinsight
Shopping
Classifieds
Homes
Jobs
Cars
Legals
Shop
Account
Settings
Subscribe
Contact Us
Support
Privacy Policy
Terms of Use
About our ads
Advertise with us
The Oklahoman
Market Watch
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biohaven Pharmaceutical Holding Company Ltd
(NY:
BHVN
)
88.78
USD
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Jan 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Biohaven Pharmaceutical Holding Company Ltd
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team
January 26, 2021
Frazier Healthcare Partners announced the planned addition of Albert Cha, M.D., Ph.D. as Managing Partner on the Life Sciences team. He has over 20 years of experience investing in public and private...
From
Business Wire News Releases
Biohaven Announces Preliminary 4Q2020 Net Product Revenue For NURTEC® ODT
January 25, 2021
- NURTEC® ODT achieved preliminary net product revenue of approximately $35 million for the fourth quarter of 2020, representing an approximately 98% increase from the prior quarter
From
PR Newswire
Notable Tuesday Option Activity: BHVN, CMG, IRBT
January 19, 2021
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Biohaven Pharmaceutical Holding Co Ltd (BHVN), where a total volume of 10,210...
Tags
Stocks
From
Market News Video
Biohaven Dives After Experimental Alzheimer's Treatment Flops In Key Test
January 19, 2021
Biohaven Pharmaceuticals said Monday its experimental Alzheimer's treatment, known as troriluzole, failed during a midstage testing process. The news sent BHVN stock into a dive Tuesday.
From
Investor's Business Daily
Why Biohaven Pharmaceutical Stock Is Tanking Today
January 19, 2021
Alzheimer's claims another drug candidate.
Tags
BHVN
Market News
From
Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 19, 2021
Gainers Tenax Therapeutics (NASDAQ:TENX) shares moved upwards by 75.28% to $3.12 during Tuesday's pre-market ...
Tags
NVCN
NRBO
ACRS
From
Benzinga
Biohaven Signs Cody Ware as Driver for Nurtec® ODT Chevrolet for the 2021 NASCAR Cup Series Season
January 18, 2021
Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Cody Ware will pilot the Nurtec® ODT (rimegepant) #51 Chevrolet Camaro for Rick Ware Racing during the 2021 NASCAR Cup Series season. The first...
From
PR Newswire
Biohaven Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program
January 18, 2021
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that it has completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical trial of...
From
PR Newswire
BiohavenPharmaHldg Meets 80-Plus Relative Strength Rating Benchmark
January 12, 2021
BiohavenPharmaHldg sees its Relative Strength Rating move into the 80-plus level.
From
Investor's Business Daily
Cramer Advises Viewers On Autodesk, Inseego And More
January 08, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said Autodesk, Inc. (NASDAQ: ADSK) is one of the best run companies in ...
Tags
Media
mad money Lightning Round
BHVN
From
Benzinga
Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs
January 07, 2021
- Acquires full ownership of Kleo Pharmaceuticals with two novel immune modulating platforms: the Multi-targeted Antibody Therapy Enhancer (MATE™) conjugation platform and Antibody Recruiting Molecule...
From
PR Newswire
Biohaven Pharmaceutical Holding Enters Oversold Territory (BHVN)
January 05, 2021
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
Biohaven's Nurtec® ODT Partners with Rick Ware Racing for 24 Hours of Daytona Entry
January 05, 2021
Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Nurtec® ODT (rimegepant) will be the primary sponsor on the #51 Ligier JS P217 entry into the LMP2 class of the 2021 24 Hours of Daytona....
From
PR Newswire
Biohaven Begins Pivotal Phase 3 Trial Of Troriluzole In Obsessive-Compulsive Disorder
January 04, 2021
- Recently completed Phase 2 proof of concept study showed drug signal for troriluzole augmentation in OCD and pivotal Phase 3 trial now initiated
From
PR Newswire
Notable Tuesday Option Activity: BHVN, GS, MKSI
December 29, 2020
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Biohaven Pharmaceutical Holding Co Ltd (BHVN), where a total of 5,088 contracts have traded...
Tags
Stocks
From
Market News Video
Noteworthy Wednesday Option Activity: AMED, RPD, BHVN
December 16, 2020
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Amedisys, Inc. (AMED), where a total of 851 contracts have traded so far, representing...
Tags
Stocks
From
Market News Video
Biohaven's Rimegepant For Preventive Treatment Of Migraine Published In The Lancet
December 16, 2020
- Rimegepant 75 mg, already approved for the acute treatment of migraine, demonstrated efficacy and safety for the preventive treatment of migraine in this pivotal Phase 3 trial in adults
From
PR Newswire
Benzinga's Top Upgrades, Downgrades For December 15, 2020
December 15, 2020
Upgrades According to Wells Fargo, the prior rating for Zynga Inc (NASDAQ: ZNGA) was changed from Equal-Weight to Overweight. ...
Tags
XYL
DE
URI
From
Benzinga
Kleo Pharmaceuticals Presents Preclinical Data on KPMW135, a Novel CD3 x CD20 Bispecific Version of Rituximab, Showing Increased Anti-Tumor Activity Compared to Rituximab, at The 62nd Annual American
December 07, 2020
Proof-of-Concept Data Demonstrates Broad Therapeutic Potential of Company’s Multi-targeted Antibody Therapy Enhancer (MATE™) Platform
From
GlobeNewswire News Releases
Biohaven's Nurtec™ ODT Partners with the Rick Ware Racing Team in the 2021 NASCAR Cup Series
December 02, 2020
Biohaven Pharmaceuticals (NYSE:BHVN) announces today that Nurtec™ ODT (rimegepant) will be the primary partner for the No. 51 Rick Ware Racing entry during the entire 2021 NASCAR Cup Series Season,...
From
PR Newswire
Notable Tuesday Option Activity: BHVN, NDLS, DOCU
December 01, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Biohaven Pharmaceutical Holding Co Ltd (BHVN), where a total volume of 10,889...
Tags
Stocks
From
Market News Video
Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
December 01, 2020
- Biohaven acquires exclusive global rights to a portfolio of novel, small-molecule CGRP antagonists
From
PR Newswire
Kleo Pharmaceuticals Announces Data Presentation on KPMW135, a Novel CD3 x CD20 Bispecific Molecule, and Conjugation Platform (MATE™) at The 62nd Annual Society of Hematology (ASH) Meeting
November 30, 2020
From
GlobeNewswire News Releases
Notable Insider Buys In The Past Week: Biglari, Coty, Danaher, Foot Locker, And More
November 28, 2020
Though buy windows remain closed for some insiders, plenty of others continued to purchase shares despite some market volatility and economic uncertainty. Here are some of the most noteworthy insider...
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Notable Insider Buys in the Past Week: Biglari, Coty, Danaher, Foot Locker And More
November 28, 2020
Insider buying can be an encouraging signal for potential investors when markets face uncertainty. This past week, some insiders ...
Tags
Benzinga
Keurig Dr Pepper
CF
From
Benzinga
Tuesday 11/24 Insider Buying Report: DHR, BHVN
November 24, 2020
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
Tags
Stocks
From
Market News Video
BioShin enrolls first patient into an Asia-Pacific regional multi-center phase III clinical trial of rimegepant (BHV-3000) for the acute treatment of migraine.
November 22, 2020
From
GlobeNewswire News Releases
Notable Thursday Option Activity: GPRE, BHVN, JACK
November 19, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Green Plains Inc. (GPRE), where a total volume of 3,707 contracts has been traded...
Tags
Stocks
From
Market News Video
Stocks That Hit 52-Week Highs On Wednesday
November 18, 2020
Before 10 a.m. ET on Wednesday, 185 stocks hit new 52-week highs. Intriguing Points: Comcast (NASDAQ: CMCSA) was the ...
Tags
RYAM
YUMC
Trading Ideas
From
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
November 17, 2020
Tuesday morning saw 69 companies set new 52-week highs. Key Facts: Qualcomm (NASDAQ: QCOM) was the company with the ...
Tags
ACHC
Financials
ROCH
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.